Top compounds associated with response to USP17L11


Feature Type Standardized
Nominal ANOVA
mRNA isoevodiamine CTRPv2 pan-cancer AAC 0.028 0.4
mRNA AT7867 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
mRNA BIRB 0796 CTRPv2 pan-cancer AAC -0.032 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
mRNA bid1870 gCSI pan-cancer AAC 0.045 0.4
mRNA Erlotinib UHNBreast pan-cancer AAC 0.25 0.4
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.026 0.4
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.03 0.4
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC 0.026 0.4
Download CSV